Report Detail
Global Montelukast Intermediate Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
- RnM4611152 |
- 19 August, 2024 |
- Global |
- 76 Pages |
- GIR (Global Info Research) |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Montelukast Intermediate market size was valued at USD 5143.4 million in 2023 and is forecast to a readjusted size of USD 6069.2 million by 2030 with a CAGR of 2.4% during review period.
Montelukast Intermediate is a leukotriene receptor antagonist (LTRA)
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines. Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.
The Global Info Research report includes an overview of the development of the Montelukast Intermediate industry chain, the market status of Asthma (GMP, Non-GMP), Allergic Rhinitis (GMP, Non-GMP), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Montelukast Intermediate.
Regionally, the report analyzes the Montelukast Intermediate markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Montelukast Intermediate market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Montelukast Intermediate market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Montelukast Intermediate industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (MT), revenue generated, and market share of different by Type (e.g., GMP, Non-GMP).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Montelukast Intermediate market.
Regional Analysis: The report involves examining the Montelukast Intermediate market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Montelukast Intermediate market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Montelukast Intermediate:
Company Analysis: Report covers individual Montelukast Intermediate manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Montelukast Intermediate This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Asthma, Allergic Rhinitis).
Technology Analysis: Report covers specific technologies relevant to Montelukast Intermediate. It assesses the current state, advancements, and potential future developments in Montelukast Intermediate areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Montelukast Intermediate market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Montelukast Intermediate market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
GMP
Non-GMP
Market segment by Application
Asthma
Allergic Rhinitis
Bronchospasm
Urticaria
Major players covered
VIVAN Life Sciences
P.G. Shah & Co.
Manus Aktteva Biopharma
Ortin Laboratories
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Montelukast Intermediate product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Montelukast Intermediate, with price, sales, revenue and global market share of Montelukast Intermediate from 2019 to 2024.
Chapter 3, the Montelukast Intermediate competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Montelukast Intermediate breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Montelukast Intermediate market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Montelukast Intermediate.
Chapter 14 and 15, to describe Montelukast Intermediate sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope of Montelukast Intermediate
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Montelukast Intermediate Consumption Value by Type: 2019 Versus 2023 Versus 2030
- 1.3.2 GMP
- 1.3.3 Non-GMP
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Montelukast Intermediate Consumption Value by Application: 2019 Versus 2023 Versus 2030
- 1.4.2 Asthma
- 1.4.3 Allergic Rhinitis
- 1.4.4 Bronchospasm
- 1.4.5 Urticaria
- 1.5 Global Montelukast Intermediate Market Size & Forecast
- 1.5.1 Global Montelukast Intermediate Consumption Value (2019 & 2023 & 2030)
- 1.5.2 Global Montelukast Intermediate Sales Quantity (2019-2030)
- 1.5.3 Global Montelukast Intermediate Average Price (2019-2030)
2 Manufacturers Profiles
- 2.1 VIVAN Life Sciences
- 2.1.1 VIVAN Life Sciences Details
- 2.1.2 VIVAN Life Sciences Major Business
- 2.1.3 VIVAN Life Sciences Montelukast Intermediate Product and Services
- 2.1.4 VIVAN Life Sciences Montelukast Intermediate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.1.5 VIVAN Life Sciences Recent Developments/Updates
- 2.2 P.G. Shah & Co.
- 2.2.1 P.G. Shah & Co. Details
- 2.2.2 P.G. Shah & Co. Major Business
- 2.2.3 P.G. Shah & Co. Montelukast Intermediate Product and Services
- 2.2.4 P.G. Shah & Co. Montelukast Intermediate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.2.5 P.G. Shah & Co. Recent Developments/Updates
- 2.3 Manus Aktteva Biopharma
- 2.3.1 Manus Aktteva Biopharma Details
- 2.3.2 Manus Aktteva Biopharma Major Business
- 2.3.3 Manus Aktteva Biopharma Montelukast Intermediate Product and Services
- 2.3.4 Manus Aktteva Biopharma Montelukast Intermediate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.3.5 Manus Aktteva Biopharma Recent Developments/Updates
- 2.4 Ortin Laboratories
- 2.4.1 Ortin Laboratories Details
- 2.4.2 Ortin Laboratories Major Business
- 2.4.3 Ortin Laboratories Montelukast Intermediate Product and Services
- 2.4.4 Ortin Laboratories Montelukast Intermediate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.4.5 Ortin Laboratories Recent Developments/Updates
3 Competitive Environment: Montelukast Intermediate by Manufacturer
- 3.1 Global Montelukast Intermediate Sales Quantity by Manufacturer (2019-2024)
- 3.2 Global Montelukast Intermediate Revenue by Manufacturer (2019-2024)
- 3.3 Global Montelukast Intermediate Average Price by Manufacturer (2019-2024)
- 3.4 Market Share Analysis (2023)
- 3.4.1 Producer Shipments of Montelukast Intermediate by Manufacturer Revenue ($MM) and Market Share (%): 2023
- 3.4.2 Top 3 Montelukast Intermediate Manufacturer Market Share in 2023
- 3.4.2 Top 6 Montelukast Intermediate Manufacturer Market Share in 2023
- 3.5 Montelukast Intermediate Market: Overall Company Footprint Analysis
- 3.5.1 Montelukast Intermediate Market: Region Footprint
- 3.5.2 Montelukast Intermediate Market: Company Product Type Footprint
- 3.5.3 Montelukast Intermediate Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Montelukast Intermediate Market Size by Region
- 4.1.1 Global Montelukast Intermediate Sales Quantity by Region (2019-2030)
- 4.1.2 Global Montelukast Intermediate Consumption Value by Region (2019-2030)
- 4.1.3 Global Montelukast Intermediate Average Price by Region (2019-2030)
- 4.2 North America Montelukast Intermediate Consumption Value (2019-2030)
- 4.3 Europe Montelukast Intermediate Consumption Value (2019-2030)
- 4.4 Asia-Pacific Montelukast Intermediate Consumption Value (2019-2030)
- 4.5 South America Montelukast Intermediate Consumption Value (2019-2030)
- 4.6 Middle East and Africa Montelukast Intermediate Consumption Value (2019-2030)
5 Market Segment by Type
- 5.1 Global Montelukast Intermediate Sales Quantity by Type (2019-2030)
- 5.2 Global Montelukast Intermediate Consumption Value by Type (2019-2030)
- 5.3 Global Montelukast Intermediate Average Price by Type (2019-2030)
6 Market Segment by Application
- 6.1 Global Montelukast Intermediate Sales Quantity by Application (2019-2030)
- 6.2 Global Montelukast Intermediate Consumption Value by Application (2019-2030)
- 6.3 Global Montelukast Intermediate Average Price by Application (2019-2030)
7 North America
- 7.1 North America Montelukast Intermediate Sales Quantity by Type (2019-2030)
- 7.2 North America Montelukast Intermediate Sales Quantity by Application (2019-2030)
- 7.3 North America Montelukast Intermediate Market Size by Country
- 7.3.1 North America Montelukast Intermediate Sales Quantity by Country (2019-2030)
- 7.3.2 North America Montelukast Intermediate Consumption Value by Country (2019-2030)
- 7.3.3 United States Market Size and Forecast (2019-2030)
- 7.3.4 Canada Market Size and Forecast (2019-2030)
- 7.3.5 Mexico Market Size and Forecast (2019-2030)
8 Europe
- 8.1 Europe Montelukast Intermediate Sales Quantity by Type (2019-2030)
- 8.2 Europe Montelukast Intermediate Sales Quantity by Application (2019-2030)
- 8.3 Europe Montelukast Intermediate Market Size by Country
- 8.3.1 Europe Montelukast Intermediate Sales Quantity by Country (2019-2030)
- 8.3.2 Europe Montelukast Intermediate Consumption Value by Country (2019-2030)
- 8.3.3 Germany Market Size and Forecast (2019-2030)
- 8.3.4 France Market Size and Forecast (2019-2030)
- 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
- 8.3.6 Russia Market Size and Forecast (2019-2030)
- 8.3.7 Italy Market Size and Forecast (2019-2030)
9 Asia-Pacific
- 9.1 Asia-Pacific Montelukast Intermediate Sales Quantity by Type (2019-2030)
- 9.2 Asia-Pacific Montelukast Intermediate Sales Quantity by Application (2019-2030)
- 9.3 Asia-Pacific Montelukast Intermediate Market Size by Region
- 9.3.1 Asia-Pacific Montelukast Intermediate Sales Quantity by Region (2019-2030)
- 9.3.2 Asia-Pacific Montelukast Intermediate Consumption Value by Region (2019-2030)
- 9.3.3 China Market Size and Forecast (2019-2030)
- 9.3.4 Japan Market Size and Forecast (2019-2030)
- 9.3.5 Korea Market Size and Forecast (2019-2030)
- 9.3.6 India Market Size and Forecast (2019-2030)
- 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
- 9.3.8 Australia Market Size and Forecast (2019-2030)
10 South America
- 10.1 South America Montelukast Intermediate Sales Quantity by Type (2019-2030)
- 10.2 South America Montelukast Intermediate Sales Quantity by Application (2019-2030)
- 10.3 South America Montelukast Intermediate Market Size by Country
- 10.3.1 South America Montelukast Intermediate Sales Quantity by Country (2019-2030)
- 10.3.2 South America Montelukast Intermediate Consumption Value by Country (2019-2030)
- 10.3.3 Brazil Market Size and Forecast (2019-2030)
- 10.3.4 Argentina Market Size and Forecast (2019-2030)
11 Middle East & Africa
- 11.1 Middle East & Africa Montelukast Intermediate Sales Quantity by Type (2019-2030)
- 11.2 Middle East & Africa Montelukast Intermediate Sales Quantity by Application (2019-2030)
- 11.3 Middle East & Africa Montelukast Intermediate Market Size by Country
- 11.3.1 Middle East & Africa Montelukast Intermediate Sales Quantity by Country (2019-2030)
- 11.3.2 Middle East & Africa Montelukast Intermediate Consumption Value by Country (2019-2030)
- 11.3.3 Turkey Market Size and Forecast (2019-2030)
- 11.3.4 Egypt Market Size and Forecast (2019-2030)
- 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
- 11.3.6 South Africa Market Size and Forecast (2019-2030)
12 Market Dynamics
- 12.1 Montelukast Intermediate Market Drivers
- 12.2 Montelukast Intermediate Market Restraints
- 12.3 Montelukast Intermediate Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Montelukast Intermediate and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Montelukast Intermediate
- 13.3 Montelukast Intermediate Production Process
- 13.4 Montelukast Intermediate Industrial Chain
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Montelukast Intermediate Typical Distributors
- 14.3 Montelukast Intermediate Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Montelukast Intermediate. Industry analysis & Market Report on Montelukast Intermediate is a syndicated market report, published as Global Montelukast Intermediate Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Montelukast Intermediate market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
